Richard J Markham Net Worth & Insider Trades

Richard J Markham - Director, Acura Pharmaceuticals, Inc

As of March 8, 2010

What is Richard J Markham's Net Worth?

The current estimated net worth of Acura Pharmaceuticals, Inc's Director, Richard J Markham, is estimated to be about $116.86M . Richard J Markham owns about 0 unit of Acura Pharmaceuticals, Inc common stock. In the last year at Acura Pharmaceuticals, Inc, Richard J Markham has sold an estimated value of $766.02K worth.

What is Richard J Markham's Past Insider Trading?

Richard J Markham's largest sale order was 35,000 units , worth over $248.85K on March 26, 2009. In total, Richard J Markham has made about 8 transactions over a year of their time at Acura Pharmaceuticals, Inc. Richard J Markham usually trades in May, with the busiest year in 2009. The most recent transaction was a sale order of 10,923 units , worth over $52.1K on March 8, 2010.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Richard Markham

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Richard J Markham's' Mailing Address?

  • Mailing address is C/o Care Capital Llc 47 Hulfish Street, Suite 310 Princeton NJ 08542 NJ

What are Acura Pharmaceuticals, Inc's Past Insider Trades?

Acura Pharmaceuticals, Inc's most recent insider trade came on January 2, 2018 by Claudius Llc, International Partners Galen III, Galen Employee Fund Iii Lp, Galen Management Llc and Partners Galen III who sold 2,195,734 units worth $219.57K . In the last 9 years, insiders at Acura Pharmaceuticals, Inc have sold an estimated value of $25.32M and bought an estimated value of $15.01M worth of shares. Insider trading is most common in January, with the busiest year in 2013. The most active traders at the company are Care Capital Ii Llc,  Care Capital Investments Ii Lp,  and Care Capital Offshore Investments Ii Lp .

ACURA PHARMACEUTICALS, INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...